The effect of the Interleukin‐6–174G > C promoter gene polymorphism on endothelial function in healthy volunteers
- 12 March 2002
- journal article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 32 (3) , 153-157
- https://doi.org/10.1046/j.1365-2362.2002.00966.x
Abstract
Aims Atherosclerosis is a chronic inflammatory condition, manifest in its early stages by endothelial dysfunction. Interleukin‐6 (IL6) plays a key role in driving this process through stimulation of acute phase protein synthesis. We have examined the effect of the IL6 gene −174G > C promoter polymorphism on endothelial function in a group of healthy subjects. Methods 248 adults aged 20–28 years participated. Polymerase chain reaction was performed for the −174G > C polymorphism. Brachial artery diameter was measured at rest and after forearm cuff occlusion by high‐resolution ultrasound. Responses were represented as absolute flow mediated dilatation (FMDA). Results Overall there was a trend towards greater FMDA for genotype CC, P = 0·14. No effect was seen in women; however, in men, following multivariate analysis, there was a significant association between genotype and FMDA, P = 0·04. In addition, a significant detrimental effect of smoking on FMDA was only seen in males of genotype CC (P < 0·05) when compared to nonsmokers of the same genotype. Conclusion IL6–174G > C promoter polymorphism influences endothelial function in healthy male subjects. The detrimental effect of smoking on endothelial function is most clearly seen in men of genotype –174 CC, suggesting a genotype‐specific interaction with smoking.Keywords
This publication has 29 references indexed in Scilit:
- C-Reactive Protein in Healthy Subjects: Associations With Obesity, Insulin Resistance, and Endothelial DysfunctionArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.Journal of Clinical Investigation, 1998
- Expression of Interleukin-6 in Atherosclerotic Lesions of Male ApoE-Knockout MiceArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation.Journal of Clinical Investigation, 1997
- Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wallAtherosclerosis, 1996
- Association of plasma fibrinogen levels with coronary artery disease, smoking and inflammatory markersAtherosclerosis, 1996
- Systemic nature of endothelial dysfunction in atherosclerosisThe American Journal of Cardiology, 1995
- 17 beta-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism.Journal of Clinical Investigation, 1994
- Interleukin 6 gene transcripts are expressed in human atherosclerotic lesionsCytokine, 1994
- Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosisThe Lancet, 1992